Neurocrine Biosciences Inc.
NBIX | NASDAQ
$145.83
-$0.27 (-0.18%)
Nov 2, 2026, 1:17 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 713M | 233M | 251.1M | 262.9M | 340.8M | 187.1M |
Short-Term Investments | 767.4M | 843.1M | 780.5M | 726.4M | 370.5M | 613.9M |
Long-Term Investments | 1.18B | 864.3M | 849.4M | 401.5M | 624.4M | 265.3M |
Other Long-Term Assets | 59.5M | 15.5M | 49.6M | 25M | 4.4M | 6.4M |
Receivables | 686.8M | 479.1M | 439.3M | 350M | 185.5M | 157.1M |
Inventory | 69M | 57.4M | 38.3M | 35.1M | 30.5M | 28M |
Other Current Assets | 115.8M | 63.6M | 97.8M | 79.1M | 45.5M | 30.1M |
Total Current Assets | 2.52B | 1.72B | 1.61B | 1.45B | 972.8M | 1.02B |
Property-Plant & Equipment | 545.2M | 592M | 347.3M | 145.6M | 155.8M | 127.4M |
Goodwill & Intangibles | n/a | 36.5M | 35.5M | 37.2M | n/a | n/a |
Total Long-Term Assets | 2.11B | 1.99B | 1.64B | 915.2M | 1.1B | 718.5M |
Total Assets | 4.63B | 3.72B | 3.25B | 2.37B | 2.07B | 1.73B |
Account Payables | 104.9M | 99.9M | 133.3M | 67.3M | 51.5M | 39.4M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 170.1M | 169.4M | n/a | n/a |
Other Current Liabilities | 423.9M | 297.8M | 261.4M | 225.4M | 133.3M | 90.6M |
Total Current Liabilities | 743.4M | 507.7M | 654.8M | 537.7M | 245.8M | 186.5M |
Long-Term Debt | n/a | n/a | n/a | n/a | 335.1M | 317.9M |
Other Long-Term Liabilities | 219.7M | 166.2M | 106.3M | 29.7M | 12.3M | 9.7M |
Total Long-Term Liabilities | 635M | 621.3M | 364.6M | 123.2M | 452.7M | 422M |
Total Liabilities | 1.38B | 1.13B | 1.02B | 660.9M | 698.5M | 608.5M |
Total Debt | 415.3M | 455.1M | 428.4M | 262.9M | 440.4M | 412.3M |
Book Value | 3.25B | 2.59B | 2.23B | 1.71B | 1.37B | 1.13B |
Book Value Per Share | 31.74 | 24.97 | 22.10 | 17.27 | 14.03 | 11.52 |
Common Stock | 100K | 100K | 100K | 100K | 100K | 100K |
Retained Earnings | 447.7M | 29.2M | -157.1M | -406.8M | -635.8M | -725.4M |
Comprehensive Income | 13.1M | 5.8M | 7M | -7.9M | -1.7M | 1.8M |
Shareholders Equity | 3.25B | 2.59B | 2.23B | 1.71B | 1.37B | 1.13B |
Total Investments | 1.95B | 1.71B | 1.63B | 1.13B | 994.9M | 879.2M |
Add to Watchlist
Select watchlists to add or remove NBIX